nsCanary™ Featured on AGA Shark Tank
NovaScan’s nsCanary™ Tech Platform Named One of Five Finalists in AGA’s Shark Tank Competition
March 02, 2023 10:00 ET | NovaScan
Chicago, IL, March 02, 2023 (GLOBE NEWSWIRE) -- NovaScan, a clinical stage oncology company, has been selected by the American Gastroenterological Association (AGA) as a finalist in its annual Shark...
Artificial Intelligence in Oncology Market Report 2022: Lower Rates of Diagnostic & Treatment Errors Brought By AI Boosts Adoption
October 07, 2022 08:43 ET | Research and Markets
Dublin, Oct. 07, 2022 (GLOBE NEWSWIRE) -- The "Artificial Intelligence in Oncology Market: Distribution by Type of Cancer, Type of End-Users and Key Geographical Regions: Industry Trends and Global...
Global Multi Cancer Early Detection Market Size/Share Worth 3186.8 Million by 2030 at a 16.5% CAGR: Custom Market Insights (Share, Report, Trends, Forecast, Trends, Segmentation)
October 05, 2022 07:30 ET | Custom Market Insights
Sandy, USA, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Multi Cancer Early Detection Market Size, Trends and Insights By Type (Liquid Biopsy,...
Future Market Insights.png
Cancer Tissue Diagnostics Market is Expected to Grow at 6.6% CAGR over 2022-2032 | Future Market Insights, Inc.
September 12, 2022 19:30 ET | Future Market Insights Global and Consulting Pvt. Ltd.
DUBAI, United Arab Emirates, Sept. 12, 2022 (GLOBE NEWSWIRE) -- The global cancer tissue diagnostics market is expected to reach a market valuation of US$ 5.3 Billion by the year 2022, accelerating...
Global Next-Generation Oncology Devices and Solutions Market
Global Next-Generation Oncology Devices and Solutions Market to Reach $5.97 Billion by 2032 at a CAGR of 6.41%
July 26, 2022 06:38 ET | Research and Markets
Dublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "Next-Generation Oncology Devices and Solutions Market - A Global and Regional Analysis: Focus on Clinical Application, End User, Type, and Region -...
Imagene logo.jpg
Imagene AI CEO Dean Bitan to Speak at FORTUNE Brainstorm Health 2022
May 09, 2022 09:49 ET | Imagene AI
Company co-founder will be interviewed May 11 by Bryan Walsh of Vox on the show’s mainstage Imagene’s deep learning algorithms use digital biopsy images to deliver real-time molecular and spatial...
Imagene AI team
Imagene AI Secures $21.5 Million to Push the Boundaries of Precision Medicine for Cancer
May 02, 2022 07:30 ET | Imagene AI
Imagene's proprietary deep learning algorithms reduce the time required for biomarkers detection from several weeks to two minutes – allowing more cancer patients to receive the most effective...
Global Market for Oncology Nutrition
Global Oncology Nutrition Markets Report 2022-2026 - Ongoing Research and Development Initiatives Fuel Demand for Oncology Nutrition Products
April 15, 2022 08:13 ET | Research and Markets
Dublin, April 15, 2022 (GLOBE NEWSWIRE) -- The "Oncology Nutrition - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Oncology Nutrition...
4D Path Announces Patented Precision Oncology Platform for Instant Biomarker Profiling and Stratification Just From H&E Biopsy or Resection Images
November 12, 2020 10:00 ET | 4D Path
NEWTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- 4D Path, a company conceived by an experienced team of scientists, clinicians and management from leading research institutions including MIT,...
artms_logo_rgb_Jan2017 150dpi.png
ARTMS Announces New Appointments to Executive Leadership Team
September 02, 2020 08:30 ET | ARTMS Products Inc.
VANCOUVER, British Columbia, Sept. 02, 2020 (GLOBE NEWSWIRE) -- ARTMS Inc. (ARTMS), the global leader in the development and commercialization of technologies that are transforming the production of...